According to Deloittte Tohmatsu serarch, the number of drug pipelines in the developmental stage from preclinical to Phase III is second only to Boston.
According to Deloittte Tohmatsu serarch, the number of drug pipelines in the developmental stage from preclinical to Phase III is second only to Boston.